Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Vector-borne diseases news, resources and funding for global health researchers

Vector-borne diseases, like malaria, dengue, and Zika, are spread by vectors. Mosquitoes, ticks, and fleas are vectors. They can spread germs through bites. Malaria alone claims hundreds of thousands of lives each year, most of them children in Africa, while up to 400 million people are infected by dengue each year. Treatments are available for some, but not all, vector-borne illnesses.

NIH supports a a wide range of programs aimed at combatting these diseases, including the Multilateral Initiative on Malaria, the Ecology and Evolution of Infectious Diseases program, a joint NIH -National Science Foundation (NSF) initiative, and Fogarty's own Global Infectious Disease program, which supports research training efforts that advance scientific discoveries, while developing local capacity in malaria research, vector biology, and vaccine development in places where it's needed most.

Fogarty's epidemiology division studies malaria transmission patterns, drug resistance, and other related topics, modeling malaria's prevalence and impact.

Fogarty Grant Recipient & Trainee Publications

Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana, co-authored by Fogarty grant recipient Yaw Asare Afrane
BMC Infectious Diseases, July 25, 2024
Prognostics of multiple malaria episodes and nutritional status in children aged 6 to 59 months from 2013 to 2017 in Dangassa, Koulikoro region, Mali, co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Soumba Keita, Mahamoudou Toure, Daouda Sanogo and Mahamadou Diakite
Malaria Journal, June 13, 2024
Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin, co-authored by Fogarty trainee L. Lorena Tapia.
Malaria Journal, May 23, 2024

NIH News and Resources

National Institute of Allergy and Infectious Diseases (NIAID)

National Library of Medicine (NLM)'s MedlinePlus

Other US Government Resources

U.S. President's Malaria Initiative (PMI)
- U.S. President's Malaria Initiative's Annual Report to Congress
Centers for Disease Control and Prevention (CDC): Vector-Borne Diseases
U.S. Agency for International Development (USAID): Malaria

Other Online Resources

Updated August 15, 2025